Quetiapine (Seroquel)

Small molecule

Approvedregulatory verdict

Evidence outlook

Approved: Schizophrenia, Bipolar Disorder

Regulatory approval supersedes design-level evidence grading; the trials behind approval are preserved below as the drug's evidence history.

track record: Partial signal

How the evidence outlook works ↗

All registered studies

Every ClinicalTrials.gov study of this drug's own program. Studies backing a featured trial above are marked Featured; the rest aren't individually graded. Filter by which indication a study was run for, then browse by phase. Studies where this drug served as another program's comparator, or is merely referenced, are listed separately below.

Phase 3 (97)
Bipolar Disorder
NCT01737268 · Astellas Pharma Inc
2012-10-29 – 2016-06-29 · Bipolar Disorder, Elderly
What this study did
NCT02362412 · Astellas Pharma Inc
2015-02-18 – 2016-02-06 · Bipolar Depression
What this study did
NCT01197846 · Centro de Investigación Biomédica en Red de Salud Mental
2010-09 – 2012-07 · Bipolar Disorder
What this study did
NCT00879307 · Hospital de Clinicas de Porto Alegre
2009-03 – 2011-09 · BIPOLAR DISORDER
What this study did
NCT00671853 · University Hospitals Cleveland Medical Center
2008-04 – 2011-03 · Bipolar Disorder, Anxiety, Anxiety Disorders, Substance Use Disorders
What this study did
NCT00857584 · AstraZeneca
Run by former owner AstraZeneca
2009-05 – 2011-02 · Bipolar Disorder, Bipolar Depression
What this study did
NCT00183443 · Palo Alto Veterans Institute for Research
2005-02 – 2010-11 · Bipolar Disorder, Schizophrenia
What this study did
NCT00252226 · Mood Disorders Center of Ottawa
2004-06 – 2007-12 · Bipolar Disorder
What this study did
NCT00277667 · Lindner Center of HOPE
2004-02 – 2007-12 · Bipolar Disorder
What this study did
NCT00227305 · AstraZeneca
Run by former owner AstraZeneca
2004-08 – 2007-12 · Schizophrenia, Bipolar I Disorder
What this study did
NCT00232414 · University of Cincinnati
2005-10 – 2007-12 · Bipolar I Disorder
What this study did
NCT00486798 · AstraZeneca
Run by former owner AstraZeneca
2007-05 – 2007-08 · Psychotic Disorders, Schizophrenia, Bipolar Disorder
What this study did
NCT00314184 · AstraZeneca
Run by former owner AstraZeneca
2005-03 – 2007-07 · Bipolar Disorder
What this study did
NCT00206141 · AstraZeneca
Run by former owner AstraZeneca
2005-08 – 2007-05 · Bipolar Disorder, Bipolar Depression, Depression
What this study did
NCT00119652 · AstraZeneca
Run by former owner AstraZeneca
2005-05 – 2007-05 · Bipolar Disorder, Bipolar Depression, Depression
What this study did
NCT00114686 · AstraZeneca
Run by former owner AstraZeneca
2006-01 – 2007-04 · Bipolar I Disorder, Alcohol Dependence
What this study did
NCT00090311 · AstraZeneca
Run by former owner AstraZeneca
2004-07 – 2006-07 · Bipolar Disorder
What this study did
NCT00448578 · AstraZeneca
Run by former owner AstraZeneca
2005-08 – 2006-06 · Mania, Bipolar Disorder
What this study did
NCT00254774 · AstraZeneca
Run by former owner AstraZeneca
2002-01 – 2006-03 · Bipolar Disorder
What this study did
NCT00097032 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
2004-10 – 2005-05 · Bipolar Disorder
What this study did
NCT00060489 · AstraZeneca
Run by former owner AstraZeneca
2002-09 – 2003-09 · Bipolar Disorder, Depression, Bipolar
What this study did
Schizophrenia
NCT05603104 · Dr. Inge Winter
2025-04-27 – 2026-06-24 · Schizophrenia and Related Disorders, Major Depressive Disorder, Bipolar Depression
What this study did
NCT02374567 · Hannover Medical School
2015-01 – 2017-06-28 · Dementia, Depression, Schizophrenia, Psychosomatic Disorders, Anxiety Disorders
What this study did
NCT01810380 · H. Lundbeck A/S
2013-03 – 2014-12 · Schizophrenia
What this study did
NCT01672554 · Corporation de Recherche en Neuropsycho Pharmacologie de Quebec
2008-12 – 2013-10 · Schizophrenia, Anxiety
What this study did
NCT02142556 · Tri-Service General Hospital (TSGH)
2008-11 – 2012-03 · Schizophrenia
What this study did
NCT01071135 · Hannover Medical School
2009-09 – 2010-08 · Schizophrenia
What this study did
NCT00882518 · AstraZeneca
Run by former owner AstraZeneca
2009-04 – 2010-07 · Schizophrenia
What this study did
NCT00640601 · AstraZeneca
Run by former owner AstraZeneca
2008-03 – 2010-07 · Schizophrenia
What this study did
NCT00852631 · AstraZeneca
Run by former owner AstraZeneca
2009-02 – 2010-05 · Schizophrenia
What this study did
NCT00640562 · AstraZeneca
Run by former owner AstraZeneca
2008-02 – 2010-02 · Schizophrenia, Depression
What this study did
NCT00347425 · Solvay Pharmaceuticals
2006-12 – 2008-02 · Schizophrenia and Schizoaffective Disorder
What this study did
NCT00334126 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
2006-04 – 2007-09 · Schizophrenia
What this study did
NCT00457899 · AstraZeneca
Run by former owner AstraZeneca
2007-07 – 2007-09 · Schizophrenia, Schizoaffective Disorders, Psychotic Disorders
What this study did
NCT00090324 · AstraZeneca
Run by former owner AstraZeneca
2004-09 – 2007-06 · Schizophrenia
What this study did
NCT00234377 · AstraZeneca
Run by former owner AstraZeneca
2004-11 – 2006-05 · Schizophrenia
What this study did
NCT00228462 · AstraZeneca
Run by former owner AstraZeneca
2005-03 – 2006-04 · Schizophrenia
What this study did
NCT00304473 · AstraZeneca
Run by former owner AstraZeneca
2004-08 – 2006-04 · Schizophrenia
What this study did
NCT00206128 · AstraZeneca
Run by former owner AstraZeneca
2004-11 – 2006-02 · Schizophrenia
What this study did
NCT00206115 · AstraZeneca
Run by former owner AstraZeneca
2004-11 – 2005-12 · Schizophrenic Disorder
What this study did
NCT00328978 · AstraZeneca
Run by former owner AstraZeneca
2003-10 – 2005-09 · Schizophrenia, Schizoaffective Disorders
What this study did
NCT00085891 · AstraZeneca
Run by former owner AstraZeneca
2004-06 – 2005-09 · Schizophrenia
What this study did
NCT00161018 · University of Maryland, Baltimore
2003-11 – 2004-11 · Schizophrenia
What this study did
Other / comorbidity
NCT07760168 · All India Institute of Medical Sciences, Bhubaneswar
2026-08-30 – 2028-08-30 · Treatment Resistant Depression (TRD)
What this study did
NCT06333990 · Foundation for Advancing Veterans' Health Research
2024-07-09 – 2028-06 · Mild Traumatic Brain Injury
What this study did
Phase 2/3 (7)
Bipolar Disorder
NCT01725308 · Astellas Pharma Inc
2012-02-07 – 2016-07-11 · Bipolar Disorder
What this study did
NCT00411463 · University of Pittsburgh
2006-12 – 2010-09 · Bipolar II Disorder
What this study did
Schizophrenia
NCT00297947 · Manhattan Psychiatric Center
2004-12 – 2014-10 · Schizophrenia, Schizoaffective Disorder
What this study did
Other / comorbidity
NCT06062953 · Lone Baandrup
2023-09-18 – 2029-02-28 · Psychiatric Disorders, Insomnia
What this study did
NCT03572257 · Medical College of Wisconsin
2019-04-15 – 2020-03-02 · Delirium
What this study did
NCT00462618 · Michael E. DeBakey VA Medical Center
2007-04 – 2008-03 · Insomnia
What this study did
NCT00215254 · Duke University
2004-03 – 2006-02 · Social Anxiety Disorder
What this study did
Phase 2 (21)
Bipolar Disorder
NCT00622245 · H. Lundbeck A/S
2008-01 – 2009-11 · Depression in Patients With Bipolar Disorder
What this study did
Schizophrenia
NCT07152184 · University Hospital, Strasbourg, France
2026-10-01 – 2032-02-01 · Patient With Schizophrenia Spectrum Disorder, NLM Classification WM 203, Psychology:Schizophrenic Psychology, Schizophrenia Spectrum and Other Psychotic Disorders
What this study did
NCT02462473 · Janssen Research & Development, LLC
2015-05 – 2016-01 · Schizophrenia, Schizoaffective Disorder
What this study did
NCT00254787 · AstraZeneca
Run by former owner AstraZeneca
2005-06 – 2006-01 · Schizophrenia
What this study did
Other / comorbidity
NCT05793632 · Ain Shams University
2023-03-01 – 2023-04-15 · Delirium
What this study did
NCT05303935 · Flinders University
2022-05-25 – 2023-04-04 · Sleep Apnea, Obstructive
What this study did
NCT01697709 · New York State Psychiatric Institute
2012-10-01 – 2017-04-30 · Cannabis Dependence
What this study did
NCT01189318 · Ewha Womans University
2012-03 – 2014-02 · Major Depressive Disorder
What this study did
NCT00674765 · University of Pennsylvania
2008-01 – 2014-01 · Alcoholism
What this study did
NCT01725282 · Astellas Pharma Inc
2011-12-14 – 2013-08-24 · Major Depressive Disorder
What this study did
NCT00872716 · University Hospital Muenster
2009-04 – 2011-03 · Specific Phobia
What this study did
NCT00954681 · New York State Psychiatric Institute
2009-08 – 2010-08 · Cannabis Dependence
What this study did
NCT00498628 · National Institute on Alcohol Abuse and Alcoholism (NIAAA)
2007-12 – 2010-03 · Alcoholism, Alcohol Abuse
What this study did
NCT00561587 · Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH
2007-11 – 2010-02 · Alcohol Relapse Prevention, Alcoholism, Alcohol Drinking, Alcohol Consumption, Alcohol Abuse
What this study did
NCT00584688 · University of South Florida
2007-02 – 2009-08 · Anorexia Nervosa
What this study did
NCT00743366 · New York State Psychiatric Institute
2008-08 – 2009-03 · Marijuana Smoking
What this study did
NCT00681668 · AstraZeneca
Run by former owner AstraZeneca
2007-08 – 2008-10 · Postpartum Depressive Disorder
What this study did
NCT00733668 · AstraZeneca
Run by former owner AstraZeneca
2006-03 – 2007-11 · Major Depressive Disorder
What this study did
NCT00254748 · AstraZeneca
Run by former owner AstraZeneca
2004-06 – 2007-06 · Borderline Personality Disorder
What this study did
NCT00318539 · AstraZeneca
Run by former owner AstraZeneca
2003-12 – 2006-08 · Obsessive Compulsive Disorder
What this study did
NCT00550147 · Indiana University
2004-02 – 2005-11 · Attention Deficit Disorder With Hyperactivity
What this study did
Phase 1/2 (3)
Schizophrenia
NCT02650102 · Shanxi Medical University
2013-01 – 2016-12 · Schizophrenia
What this study did
Other / comorbidity
NCT02087631 · University of Calgary
2014-12 – 2019-07 · Multiple Sclerosis
What this study did
NCT02056171 · Weill Medical College of Cornell University
2015-03 – 2016-12 · Delirium
What this study did
Phase 1 (28)
Bipolar Disorder
NCT03872596 · Otsuka Pharmaceutical Development & Commercialization, Inc.
2019-03-27 – 2019-11-27 · Bipolar Disorder, Schizophrenia
What this study did
NCT02087579 · Janssen Research & Development, LLC
2014-02 – 2014-12 · Psychotic Disorders, Schizophrenia, Bipolar Disorder, Depressive Disorder
What this study did
Schizophrenia
NCT02901587 · H. Lundbeck A/S
2016-09 – 2018-04-18 · Schizophrenia, Schizoaffective Disorder
What this study did
NCT02051387 · Central Institute of Mental Health, Mannheim
2013-01 – 2017-08 · Schizophrenia
What this study did
NCT00919607 · AstraZeneca
Run by former owner AstraZeneca
2009-06 – 2010-03 · Schizophrenia
What this study did
Other / comorbidity
NCT06546358 · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
2024-09 – 2025-12 · Postpartum Depression
What this study did
NCT04950868 · Verinder Sharma
2022-03-18 – 2025-06-01 · Postpartum Depression
What this study did
NCT05240261 · Assiut University
2022-05-01 – 2024-12-31 · Chronic Kidney Diseases
What this study did
NCT04280965 · The University of Texas Health Science Center at San Antonio
2019-02-01 – 2022-10-17 · Post Traumatic Stress Disorder
What this study did
NCT05235230 · Future University in Egypt
2021-05-19 – 2021-06-03 · Bioequivalence
What this study did
NCT04310579 · Food and Drug Administration (FDA)
2020-06-15 – 2021-05-25 · Hypercapnia, Ventilatory Depression
What this study did
NCT00087750 · National Institute on Drug Abuse (NIDA)
started 2003-10 · Cocaine-Related Disorders
What this study did
NCT02131545 · Mayo Clinic
2014-06 – 2016-07 · Dementia, Delirium
What this study did
NCT01871701 · Seoul National University Hospital
2012-11 – 2014-05 · Healthy
What this study did
NCT00606541 · Duke University
2008-01 – 2012-11 · Social Anxiety Disorder
What this study did
NCT01607762 · Janssen Research & Development, LLC
2012-02 – 2012-10 · Healthy
What this study did
NCT01919008 · Astellas Pharma Inc
2012-03-26 – 2012-06-22 · Major Depressive Disorder
What this study did
NCT01400165 · University of Ottawa
2011-07 – 2011-12 · Healthy
What this study did
NCT01903200 · Astellas Pharma Inc
2010-02 – 2011-09 · Major Depressive Disorder Patients
What this study did
NCT01908296 · Astellas Pharma Inc
2011-07 – 2011-08 · Healthy, Pharmacokinetics of Quetiapine
What this study did
NCT01924520 · Astellas Pharma Inc
2010-11 – 2011-05 · Major Depressive Disorder
What this study did
NCT01566487 · Dr. Reddy's Laboratories Limited
2010-06 – 2010-06 · Healthy
What this study did
NCT01871974 · Astellas Pharma Inc
2009-05 – 2010-03 · Major Depressive Disorder Patients
What this study did
NCT00832221 · AstraZeneca
Run by former owner AstraZeneca
2009-01 – 2009-09 · Depression
What this study did
NCT00567866 · University of Arkansas
2008-01 – 2009-09 · Methamphetamine Dependence
What this study did
NCT01871987 · Astellas Pharma Inc
2009-06 – 2009-08 · Healthy, Plasma Concentration Change of Quetiapine
What this study did
NCT00702676 · AstraZeneca
Run by former owner AstraZeneca
2008-07 – 2008-08 · Healthy Volunteers
What this study did
NCT00255879 · University of California, San Diego
1999-01 – 2004-08 · Dyskinesia, Drug-Induced
What this study did
Phase 4 (112)
Bipolar Disorder
NCT06433635 · Massachusetts General Hospital
2024-10-01 – 2030-02-28 · Bipolar I Disorder, Depression
What this study did
NCT02845453 · Boston Medical Center
2017-01-20 – 2021-04-07 · Substance Use Disorders, Bipolar Disorder, Mood Disorders
What this study did
NCT01938859 · Shanghai Mental Health Center
2012-06 – 2018-12 · Bipolar Disorder
What this study did
NCT01588457 · The University of Texas Health Science Center at San Antonio
2011-06 – 2016-12 · Bipolar I Disorder, Bipolar II Disorder
What this study did
NCT01893229 · Guiyun Xu
2013-09 – 2015-12 · Bipolar Disorder
What this study did
NCT01133821 · Holly Swartz
2010-08 – 2015-10 · Bipolar Disorder, Depression
What this study did
NCT01526148 · University Hospitals Cleveland Medical Center
2012-01 – 2015-01 · Bipolar Disorder
What this study did
NCT00393978 · University of Cincinnati
2006-11 – 2014-03 · Bipolar Disorder, Cannabis-Related Disorder
What this study did
NCT01331304 · Massachusetts General Hospital
2010-09 – 2013-09 · Bipolar Disorder
What this study did
NCT00746421 · Emory University
2010-01 – 2012-04 · Bipolar Disorder, Cognitive Impairment
What this study did
NCT00186043 · Stanford University
2008-08 – 2011-08 · Bipolar II Disorder
What this study did
NCT00457197 · University of Texas Southwestern Medical Center
2007-03 – 2011-07 · Bipolar Disorder, Alcohol Dependence
What this study did
NCT01195363 · The University of Texas Health Science Center at San Antonio
2007-04 – 2011-06 · Bipolar Disorder
What this study did
NCT00579280 · University of South Florida
2007-07 – 2010-12 · Bipolar Disorder, Panic Disorder, Generalized Anxiety Disorder
What this study did
NCT00550394 · University of Cincinnati
2008-04 – 2010-06 · Bipolar Disorder, Alcohol Abuse
What this study did
NCT00521365 · AstraZeneca
Run by former owner AstraZeneca
2008-05 – 2009-08 · Bipolar Disorder, Bipolar Affective Psychosis, Mania, Manic Disorder, Manic State
What this study did
NCT00672490 · AstraZeneca
Run by former owner AstraZeneca
2008-04 – 2009-07 · Acute Mania in Bipolar Disorder
What this study did
NCT00181883 · Massachusetts General Hospital
2005-02 – 2009-04 · Bipolar Disorder, Mania
What this study did
NCT00223210 · University of Texas Southwestern Medical Center
2005-11 – 2007-12 · Bipolar Disorder, Cocaine Dependence
What this study did
NCT00048802 · Northwell Health
2002-08 – 2006-08 · Bipolar Disorder
What this study did
NCT00139074 · AstraZeneca
Run by former owner AstraZeneca
2005-07 – 2006-06 · Bipolar Disorder
What this study did
NCT00223249 · University of Texas Southwestern Medical Center
2002-11 – 2004-08 · Bipolar Disorder, Alcohol Abuse/Dependence
What this study did
NCT00182013 · Massachusetts General Hospital
2001-06 – 2004-02 · Bipolar Spectrum Disorder
What this study did
Schizophrenia
NCT04446234 · Shanghai Mental Health Center
2021-05 – 2022-12-31 · Schizophrenia
What this study did
NCT03568500 · Otsuka Pharmaceutical Development & Commercialization, Inc.
2018-05-21 – 2019-09-06 · Schizophrenia, Schizoaffective Disorder, First Episode Psychosis
What this study did
NCT02307396 · Technical University of Munich
2015-02-01 – 2016-06-22 · Schizophrenia, Schizophrenia and Disorders With Psychotic Features, Schizoaffective Disorders
What this study did
NCT02526030 · Fundación Marques de Valdecilla
2008-10 – 2015-06 · Schizophrenia, Psychotic Disorders
What this study did
NCT02305823 · Fundación Marques de Valdecilla
2005-10 – 2014-05 · Schizophrenia, Psychotic Disorders
What this study did
NCT01164059 · University of Bremen
2010-02 – 2014-03 · Schizophrenia
What this study did
NCT02534363 · Fundación Marques de Valdecilla
2005-10 – 2013-01 · Schizophrenia, Psychotic Disorders
What this study did
NCT01250847 · Severance Hospital
2010-11 – 2012-10 · Abnormal Mental State, Schizophrenia
What this study did
NCT01213836 · AstraZeneca
Run by former owner AstraZeneca
2010-11 – 2011-08 · Schizophrenia
What this study did
NCT00511277 · Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH
2007-08 – 2011-04 · Schizophrenia
What this study did
NCT00554658 · University of Regensburg
2008-03 – 2011-03 · Schizophrenia
What this study did
NCT00986167 · Bayside Health
2009-10 – 2010-10 · Schizophrenia, Psychosis
What this study did
NCT01047215 · Taichung Veterans General Hospital
2009-08 – 2010-06 · Schizophrenia, Bipolar
What this study did
NCT00817648 · Shanghai Mental Health Center
2008-12 – 2010-05 · Schizophrenia
What this study did
NCT00954122 · AstraZeneca
Run by former owner AstraZeneca
2009-09 – 2010-04 · Schizophrenia
What this study did
NCT00779506 · AstraZeneca
Run by former owner AstraZeneca
2008-11 – 2009-07 · Schizophrenia
What this study did
NCT00797927 · National Taiwan University Hospital
2007-01 – 2009-04 · Schizophrenia
What this study did
NCT00044655 · Icahn School of Medicine at Mount Sinai
2001-07 – 2009-03 · Schizophrenia
What this study did
NCT00681629 · AstraZeneca
Run by former owner AstraZeneca
2008-07 – 2008-11 · Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder
What this study did
NCT00206102 · AstraZeneca
Run by former owner AstraZeneca
2003-09 – 2008-10 · Schizophrenia, Schizoaffective Disorder
What this study did
NCT00156715 · Dartmouth-Hitchcock Medical Center
2004-03 – 2008-10 · Schizophrenia, Schizoaffective Disorder, Psychotic Disorder, Substance Abuse, Alcohol Abuse
What this study did
NCT00498004 · Inje University
2007-08 – 2008-09 · Schizophrenia
What this study did
NCT00370500 · University of Erlangen-Nürnberg Medical School
2007-04 – 2008-07 · Schizophrenia
What this study did
NCT00255515 · AstraZeneca
Run by former owner AstraZeneca
2005-09 – 2007-12 · Schizophrenia
What this study did
NCT00304616 · Korea Otsuka Pharmaceutical Co., Ltd.
2004-10 – 2007-10 · Schizophrenia
What this study did
Early phase / not applicable (35)
Bipolar Disorder
NCT05480150 · First Affiliated Hospital of Zhejiang University
2021-11-01 – 2026-12-31 · Major Depressive Disorder, Bipolar Disorder, Mixed, Affective; Disorder, Organic
What this study did
NCT05098353 · Federal Stare Budgetary Scientific Institution, Mental Health Research Center
2021-04-10 – 2021-12-01 · Bipolar Affective Disorder
What this study did
NCT02451306 · RWTH Aachen University
2015-06 – 2018-05 · Depression, Bipolar Disorder
What this study did
NCT00893581 · University of Cincinnati
2009-03 – 2016-03 · Mania, Bipolar Disorder
What this study did
NCT00742638 · Shanghai Jiao Tong University School of Medicine
2008-03 – 2010-08 · Bipolar Disorder
What this study did
NCT01527448 · BC Women's Hospital & Health Centre
2008-04 – 2010-07 · Postpartum Depression
What this study did
NCT01570959 · Roxane Laboratories
2007-04 – 2007-11 · Bipolar I Disorder
What this study did
NCT01570894 · Roxane Laboratories
2007-07 – 2007-07 · Bipolar I Disorder
What this study did
NCT01570907 · Roxane Laboratories
2007-06 – 2007-07 · Treatment for Bipolar I Disorder
What this study did
NCT00227123 · University of Texas Southwestern Medical Center
2002-10 – 2006-11 · Bipolar Disorder, Cocaine Dependence, Methamphetamine Dependence
What this study did
Schizophrenia
NCT00642369 · Guang Dong Provincial Mental Health Institute
2008-03 – 2009-10 · Schizophrenia
What this study did
NCT00493233 · Centre for Addiction and Mental Health
2006-11 – 2008-12 · Schizophrenia
What this study did
NCT00515723 · Washington University School of Medicine
2001-09 – 2008-12 · Schizophrenia, Schizoaffective Disorder, Type 2 Diabetes Mellitus, Hyperglycemia
What this study did
NCT00207064 · Birte Glenthoj
2004-04 – 2008-09 · Schizophrenia
What this study did
NCT00222495 · University of Minnesota
2002-08 – 2006-08 · Psychotic Disorders, Schizophrenia, Schizophreniform Disorders, Schizoaffective Disorders
What this study did
NCT00231101 · Arthur P. Noyes Research Foundation
2004-01 – 2006-06 · Smoking Behavior in Schizophrenia
What this study did
NCT00018642 · US Department of Veterans Affairs
1997-04 – 2002-03 · Schizophrenia, Schizoaffective Disorder
What this study did
Other / comorbidity
NCT04728581 · St. Anna Ziekenhuis, Geldrop, Netherlands
2024-01-01 – 2027-01-01 · Osteo Arthritis Knee, Insomnia
What this study did
NCT05801289 · Ain Shams University
2022-12-04 – 2023-04 · Delirium
What this study did
NCT04209166 · Shanghai Mental Health Center
2019-08-12 – 2022-10-31 · Major Depressive Disorder
What this study did
NCT06200584 · Dr Rabia Arshad
2021-01-01 – 2021-06-10 · Antipsychotics and Neuroleptics Toxicity
What this study did
NCT02467933 · Abdul Latif Jameel Poverty Action Lab
2015-04 – 2017-04 · Economics, Fraud, Delivery of Health Care, Health Expenditures, Centers for Medicare and Medicaid Services (U.S.)
What this study did
NCT01066156 · Cambridge Health Alliance
2010-02 – 2015-03 · Post-Traumatic Stress Disorder
What this study did
NCT02137616 · Central South University
2012-06 – 2014-12 · Psychotic Disorders
What this study did
NCT00688818 · Centre for Addiction and Mental Health
2008-06 – 2013-06 · Major Depressive Disorder, Dysthymic Disorder, Anxiety Disorders, Generalized Anxiety Disorder, Social Anxiety Disorder, Panic Disorder, Post-traumatic Stress Disorder
What this study did
NCT01971203 · Icahn School of Medicine at Mount Sinai
2009-09 – 2013-06 · Major Depressive Disorder, Generalized Anxiety Disorder
What this study did
NCT00617396 · University of North Carolina, Chapel Hill
2008-02 – 2012-05 · Functional Bowel Disorders
What this study did
NCT00631748 · Seattle Institute for Biomedical and Clinical Research
2008-02 – 2010-07 · Cocaine Dependence, Cocaine Abuse, Cocaine Addiction, Drug Abuse, Substance Abuse
What this study did
NCT00518973 · University of California, San Diego
2006-07 – 2010-05 · Anorexia Nervosa
What this study did
NCT00232570 · University of Vermont
2005-11 – 2010-01 · Alzheimer's Disease, Insomnia
What this study did
NCT00328822 · Khon Kaen University
2006-12 – 2007-08 · Primary Insomnia
What this study did
NCT00280501 · Medical University of Vienna
2005-08 – 2006-08 · Regional Blood Flow, Ocular Physiology
What this study did
NCT00015548 · National Institute of Mental Health (NIMH)
2001-03 – 2004-10 · Alzheimer's Disease
What this study did
Used as active comparator (39)

Other programs' studies in which this drug was the registered active-comparator arm: a marker of standard-of-care status, not evidence of this drug's own progression.

Phase 3 (15)
Bipolar Disorder
NCT00857818 · Otsuka Pharmaceutical Development & Commercialization, Inc.
2009-04 – 2010-03 · Schizophrenia, Schizoaffective Disorder, Bipolar I Disorder, Metabolic Syndrome
What this study did
NCT00309699 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
2006-04 – 2007-11 · Bipolar Disorder, Mood Disorders
What this study did
Schizophrenia
NCT04115319 · Otsuka Pharmaceutical Development & Commercialization, Inc.
2019-11-21 – 2022-12-30 · Schizophrenia
What this study did
NCT03465787 · Bukwang Pharmaceutical
2018-04-09 – 2022-10-26 · Schizophrenia
What this study did
NCT00789698 · Sumitomo Pharma America, Inc.
2008-12 – 2011-07 · Chronic Schizophrenia
What this study did
NCT00790192 · Sumitomo Pharma America, Inc.
2008-10 – 2010-07 · Schizophrenia
What this study did
NCT00654706 · H. Lundbeck A/S
2008-03 – 2010-03 · Schizophrenia, Cognition
What this study did
NCT00704509 · H. Lundbeck A/S
2008-06 – 2009-11 · Schizophrenia
What this study did
NCT00658645 · H. Lundbeck A/S
2008-03 – 2009-11 · Schizophrenia
What this study did
NCT00396214 · Solvay Pharmaceuticals
2007-04 – 2008-01 · Schizophrenia
What this study did
NCT00216476 · Janssen-Cilag International NV
2004-10 – 2007-11 · Schizophrenia, Psychotic Disorders
What this study did
Other / comorbidity
NCT00315900 · Tuscaloosa Research & Education Advancement Corporation
2006-05-01 – 2008-02-28 · Agitation, Dementia
What this study did
Phase 2/3 (1)
Schizophrenia
NCT01129674 · Denovo Biopharma LLC
2010-06 – 2012-10 · Schizophrenia
What this study did
Phase 2 (5)
Bipolar Disorder
NCT07654348 · First Affiliated Hospital of Zhejiang University
2026-07-01 – 2029-07-01 · Bipolar Disorder II
What this study did
NCT00771134 · H. Lundbeck A/S
2008-12 – 2009-08 · Bipolar Disorder
What this study did
Other / comorbidity
NCT04521478 · Boehringer Ingelheim
2020-11-20 – 2024-02-02 · Depressive Disorder, Major
What this study did
NCT04164758 · ACADIA Pharmaceuticals Inc.
2019-10-23 – 2020-09-25 · Parkinson's Disease
What this study did
Phase 1 (4)
Schizophrenia
NCT05542264 · Otsuka Pharmaceutical Development & Commercialization, Inc.
2022-11-15 – 2024-02-12 · Schizophrenia
What this study did
NCT05402111 · Otsuka Pharmaceutical Development & Commercialization, Inc.
2022-06-13 – 2023-09-27 · Schizophrenia
What this study did
Other / comorbidity
NCT01603173 · IPCA Laboratories Ltd.
2011-04 – 2011-11 · Fasting State
What this study did
NCT01603186 · IPCA Laboratories Ltd.
2011-04 – 2011-11 · Fed
What this study did
Phase 4 (12)
Bipolar Disorder
NCT02562287 · Hospital de Clinicas de Porto Alegre
2015-10 – 2020-12 · Bipolar Disorder
What this study did
NCT00397020 · University of California, San Diego
2006-12 – 2008-12 · Bipolar Disorder
What this study did
Schizophrenia
NCT02282085 · Matt Byerly
2014-12 – 2017-12 · Schizophrenia
What this study did
NCT01157351 · Janssen Scientific Affairs, LLC
2010-05 – 2013-12 · Schizophrenia
What this study did
NCT01193166 · Ortho-McNeil Janssen Scientific Affairs, LLC
2010-08 – 2012-09 · Schizophrenia
What this study did
NCT00330863 · Northwell Health
2006-05 – 2011-01 · Schizophrenia, Schizoaffective Disorder
What this study did
NCT00423878 · National Institute of Mental Health (NIMH)
2007-01 – 2010-03 · Schizophrenia, Schizoaffective Disorder
What this study did
NCT00508157 · Otsuka Pharmaceutical Development & Commercialization, Inc.
2007-11-01 – 2009-03-01 · Metabolic Syndrome, Schizophrenia
What this study did
NCT00654576 · Central South University
2005-02 – 2007-12 · Schizophrenia
What this study did
Other / comorbidity
NCT05085808 · University of Southern California
2028-03-01 – 2030-12-01 · Delirium, Morality, Quality of Life, Psych, Treatment Side Effects
What this study did
NCT04936126 · All India Institute of Medical Sciences, Bhubaneswar
2021-08-07 – 2024-09-07 · Treatment Resistant Depression
What this study did
NCT00806234 · Johns Hopkins University
2009-01 – 2014-03 · Psychotic Disorders
What this study did
Early phase / not applicable (2)
Schizophrenia
NCT02192723 · Beijing HuiLongGuan Hospital
2012-06 – 2014-06 · Schizophrenia
What this study did
Other / comorbidity
NCT06581302 · Shanghai Jiao Tong University School of Medicine
2024-09-01 – 2025-12-30 · Psychotic Disorders
What this study did
Appears in other studies (10)

Studies that reference this drug without giving it an intervention arm of its own: other formulations' programs, background therapy, or registry-search bleed.

Phase 3 (3)
Schizophrenia
NCT00237913 · Otsuka Pharmaceutical Development & Commercialization, Inc.
2004-07 – 2005-08 · Schizophrenia
What this study did
NCT00159770 · Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
2001-11 – 2004-09 · Schizophrenia, Schizoaffective Disorder, Psychotic Disorders
What this study did
Other / comorbidity
NCT01858948 · University of Cincinnati
2013-07 – 2018-04 · Bipolar Youth Treated With Second-generation Antipsychotics
What this study did
Phase 2 (4)
Schizophrenia
NCT03557931 · Astellas Pharma Global Development, Inc.
2018-07-13 – 2019-10-21 · Schizophrenia
What this study did
NCT00509067 · Georgetown University
2007-11 – 2011-03 · Schizophrenia
What this study did
Other / comorbidity
NCT00893841 · Dr. D McIntosh & Dr. K Kjernisted Clinical Research Inc.
2009-02 – 2013-01 · Bipolar Depression
What this study did
NCT01165541 · Dartmouth-Hitchcock Medical Center
2010-09 – 2012-10 · Alcohol Dependence
What this study did
Phase 4 (2)
Schizophrenia
NCT02040883 · Qingyun Yin
2014-02 – 2014-12 · Schizophrenia
What this study did
NCT00325689 · Otsuka Pharmaceutical Development & Commercialization, Inc.
2006-07 – 2007-10 · Schizophrenia, Schizoaffective Disorder
What this study did
Early phase / not applicable (1)
Schizophrenia
NCT03019887 · Juntendo University
2011-04 – 2017-01 · Schizophrenia Relapse
What this study did

Competitive landscape

This mechanism is crowded: 24 other tracked programmes target it, none of them ahead of this one.

This drug's own stage for Bipolar Disorder: Approved. Competitors below are sorted furthest-along first.

DrugStageModalityMechanismEvidence signalReported efficacygraded featured trials
Quetiapine (Seroquel): this drugApprovedSmall moleculeDopamine D2 and serotonin 5-HT2A receptors (antagonist)not yet gradedNo reviewed efficacy summary in this indication
Aripiprazole (Abilify Maintena)ApprovedSmall moleculeDopamine D2 and serotonin 5-HT1A receptors (partial agonist), Dopamine D2/D3 and serotonin 5-HT1A receptor, Dopamine D2 receptor (partial agonist)not yet gradedNo reviewed efficacy summary in this indication
Aripiprazole (Abilify)ApprovedSmall moleculeDopamine D2/D3 and serotonin 5-HT1A receptornot yet gradedNo reviewed efficacy summary in this indication
AsenapineApprovedSmall moleculeDopamine D2 and serotonin 5-HT2A receptors (antagonist)not yet gradedNo reviewed efficacy summary in this indication
Cariprazine (Vraylar)ApprovedSmall moleculeDopamine D3/D2 receptor (partial agonist)not yet gradedNo reviewed efficacy summary in this indication
Divalproex Sodium (Depakote ER)ApprovedSmall moleculeGABAergic neurotransmissionnot yet gradedNo reviewed efficacy summary in this indication
Divalproex Sodium (Depakote)ApprovedSmall moleculeGABAergic neurotransmissionPartial signalFeatured results are non-efficacy only in this race
Iloperidone (Fanapt)ApprovedSmall moleculeDopamine D2 and serotonin 5-HT2A receptors (antagonist)not yet gradedNo reviewed efficacy summary in this indication
LamotrigineApprovedSmall moleculeVoltage-gated sodium channelnot yet gradedNo reviewed efficacy summary in this indication
Milsaperidone (VHX-896)ApprovedSmall moleculeDopamine D2 and serotonin 5-HT2A receptors (antagonist)Weak signalNo reviewed efficacy summary in this indication
Olanzapine (Zyprexa)ApprovedSmall moleculeDopamine D2 and serotonin 5-HT2A receptors (antagonist)not yet gradedNo reviewed efficacy summary in this indication
Olanzapine / Samidorphan (Lybalvi)ApprovedSmall moleculeDopamine D2 and serotonin 5-HT2A receptors (antagonist); mu-opioid receptor (antagonist)Reliable signalNo reviewed efficacy summary in this indication
Quetiapine (Seroquel XR)ApprovedSmall moleculeDopamine D2 and serotonin 5-HT2A receptors (antagonist)not yet gradedNo reviewed efficacy summary in this indication
Risperidone (Risperdal Consta)ApprovedSmall moleculeDopamine D2 and serotonin 5-HT2A receptors (antagonist)not yet gradedNo reviewed efficacy summary in this indication
Risperidone (Risperdal)ApprovedSmall moleculeDopamine D2 and serotonin 5-HT2A receptors (antagonist)not yet gradedNo reviewed efficacy summary in this indication
Risperidone (Rykindo)ApprovedSmall moleculeDopamine D2 and serotonin 5-HT2A receptors (antagonist)not yet gradedNo reviewed efficacy summary in this indication
Risperidone (Uzedy)ApprovedSmall moleculeDopamine D2 and serotonin 5-HT2A receptors (antagonist)not yet gradedNo reviewed efficacy summary in this indication
ZiprasidoneApprovedSmall moleculeDopamine D2 and serotonin 5-HT2A receptors (antagonist)not yet gradedNo reviewed efficacy summary in this indication
Dexmedetomidine (Igalmi)Phase 3Small moleculeAlpha-2 adrenergic receptor (agonist)Reliable signalNo reviewed efficacy summary in this indication
Loxapine (Adasuve)Phase 3Small moleculeDopamine D2 and serotonin 5-HT2A receptors (antagonist)Partial signalNo reviewed efficacy summary in this indication
Xanomeline / Trospium Chloride (Cobenfy)Phase 3Small moleculeMuscarinic M1/M4 receptor (agonist/antagonist combination)not yet gradedNo reviewed efficacy summary in this indication
ALTO-100Phase 2Small moleculeFirst-in-class oral small molecule neural plasticity enhancernot yet gradedNo reviewed efficacy summary in this indication
BrenipatidePhase 2PeptideGLP-1/GIP receptor (dual)not yet gradedNo reviewed efficacy summary in this indication
ElunetiromPhase 2Small moleculeThyroid hormone receptor-betanot yet gradedNo reviewed efficacy summary in this indication
IcalcaprantPhase 2Small moleculeKappa-opioid receptor (inhibitor)not yet gradedNo reviewed efficacy summary in this indication
Lithium Salicylate / L-Proline (AL001)Phase 1/2Small molecule—not yet gradedNo reviewed efficacy summary in this indication
ABBV-1042
Phase 1(overall)
Small moleculeMuscarinic M4 receptornot yet gradedNo reviewed efficacy summary in this indication
Aripiprazole (Abilify MyCite)DiscontinuedCombinationDopamine D2 and serotonin 5-HT1A receptors (partial agonist); serotonin 5-HT2A receptor (antagonist)not yet gradedNo reviewed efficacy summary in this indication

Upcoming events

(8 total)

Estimated primary-completion dates from ClinicalTrials.gov. These are registry estimates, never confirmed readout dates; they can move as trials progress.

Follow Quetiapine (Seroquel) to get an email as a readout nears, when a date moves, or when a study changes status. Needs a free account.

Add these readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.

2026 (1)
December 2026 (1)
Early phase / not applicableBipolar DisorderRecruiting
Est. primary completion 2026-12-31 · NCT05480150 · CT.gov ↗
What to watch
2027 (1)
October 2027 (1)
Phase 4Parkinson's Disease PsychosisRecruiting
Est. primary completion 2027-10-24 · NCT04373317 · CT.gov ↗
What to watch
2028 (3)
June 2028 (2)
Phase 3Mild Traumatic Brain InjuryRecruiting
Est. primary completion 2028-06 · NCT06333990 · CT.gov ↗
What to watch
Phase 3Bipolar DepressionRecruiting
Est. primary completion 2028-06-30 · NCT05973786 · CT.gov ↗
What to watch
August 2028 (1)
Phase 3Treatment Resistant Depression (TRD)Not yet recruiting
Est. primary completion 2028-08-30 · NCT07760168 · CT.gov ↗
What to watch
2029 (1)
February 2029 (1)
Phase 2/3Psychiatric Disorders, InsomniaRecruiting
Est. primary completion 2029-02-28 · NCT06062953 · CT.gov ↗
What to watch
2030 (1)
February 2030 (1)
Phase 4Bipolar DisorderActive not recruiting
Est. primary completion 2030-02-28 · NCT06433635 · CT.gov ↗
What to watch
2032 (1)
February 2032 (1)
Phase 2SchizophreniaNot yet recruiting
Est. primary completion 2032-02-01 · NCT07152184 · CT.gov ↗
What to watch

See the full readout calendar ↗